Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Name: Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
License: Public Domain

City of Hope Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

mantle cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 253002
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.